TB Diagnostics
R-Biopharm
Next-generation IGRA alternatives with higher sensitivity than QuantiFERON.
R-Biopharm's RIDASCREEN IP-10 and RIDA QUICK TB represent the next generation of tuberculosis diagnostics. IP-10 is produced at 100x higher concentration than interferon-gamma, enabling detection of TB infection in immunocompromised patients where traditional IGRAs produce indeterminate results.
Key Products
RIDASCREEN IP-10
ELISA-based TB detection measuring IP-10 biomarker. 100x higher signal than IFN-γ. Works on existing ELISA platforms.
RIDA QUICK TB
Rapid lateral flow TB screening test. Visual result in 10 minutes from whole blood.
RIDA GENE RT-PCR
Real-time PCR for M. tuberculosis complex detection and rifampicin resistance.
Why Choose This Solution
- IP-10 biomarker at 100x concentration vs interferon-gamma
- Detects TB in HIV+ and immunocompromised patients (fewer indeterminates)
- Runs on existing ELISA equipment — no capital expenditure
- RIDA QUICK: 10-minute screening for field and clinic use
- PCR confirmation with rifampicin resistance detection
Caribbean-Specific Advantages
- Caribbean HIV prevalence creates high demand for reliable TB testing
- IP-10 works in immunocompromised populations where QuantiFERON fails
- No new capital equipment needed — uses existing ELISA platforms
- Supports Caribbean TB elimination programs and PAHO targets
Ready to learn more?
Contact us for pricing, product demonstrations, and site assessment for your laboratory.
Caribbean Diagnostics | 6901 Professional Parkway East, 2nd Floor, Sarasota, FL 34240
33 Caribbean Territories | 57+ Global Vendors | 25+ Years Experience